CYTOKINE CHANGES IN THROMBOTIC THROMBOCYTOPENIC PURPURA FOLLOWING KIDNEY-TRANSPLANTATION

被引:0
|
作者
BURKE, GW
CIROCCO, R
CARRENO, M
PARDO, V
ROTH, D
CASTILLO, A
TEMPLE, JD
ESQUENAZI, V
MILGROM, M
MILLER, J
机构
关键词
KIDNEY TRANSPLANTATION; THROMBOTIC; THROMBOCYTOPENIC PURPURA; CYTOKINES; INTERLEUKIN-1; INTERLEUKIN-2; GAMMA-INTERFERON; RECEPTOR;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
The occurrence of thrombotic thrombocytopenic purpura (TTP) following kidney transplantation is rare. We report a patient who developed TTP within 36 hours of kidney transplantation. For 5 months preoperatively, serum levels of Interleukin-2 (IL-2) and gamma interferon (IFN-G) were markedly elevated. Subsequent to kidney transplantation and steroid administration, thrombocytopenia, with schistocytic anemia and severe neurologic changes (TTP), abruptly occurred. This was associated with a dramatic fall in the levels of IL-2 and gamma-IFN. There was no clinical improvement with plasmapheresis. The patient's serum was not cytotoxic when added with complement to the donor renal vein endothelial cells in vitro. Removal of the allograft corrected the TTP.
引用
收藏
页码:47 / 51
页数:5
相关论文
共 50 条
  • [31] A very rare complication of carbon monoxide intoxication; thrombotic thrombocytopenic purpura
    Ozkayar, Nihal
    Piskinpasa, Serhan
    Bulut, Mesudiye
    Oguz, Ebru Gok
    Turhan, Turan
    Dogan, Halef Okan
    Dede, Fatih
    Turkish Journal of Biochemistry-Turk Biyokimya Dergisi, 2014, 39 (04): : 571 - 573
  • [32] FACTORS AFFECTING THE LONG-TERM OUTCOME FOLLOWING NONLIVING KIDNEY-TRANSPLANTATION
    THOROGOOD, J
    VANHOUWELINGEN, JC
    VANROOD, JJ
    ZANTVOORT, FA
    SCHREUDER, GMT
    PERSIJN, GG
    TRANSPLANT INTERNATIONAL, 1992, 5 : S138 - S139
  • [33] ATRIAL-NATRIURETIC-PEPTIDE RELEASE AND VOLUME REGULATION FOLLOWING KIDNEY-TRANSPLANTATION
    ZUBER, M
    KIOWSKI, W
    HUSER, B
    ERNE, P
    BUHLER, FR
    THIEL, G
    CLINICAL NEPHROLOGY, 1993, 40 (02) : 91 - 95
  • [34] Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patients
    P. Knöbl
    C. Rintelen
    G. Kornek
    C. Wiltschke
    P. Kalhs
    I. Schwarzinger
    S. Globits
    T. Staudinger
    K. Laczika
    P. Kyrle
    M. Frass
    Intensive Care Medicine, 1997, 23 : 44 - 50
  • [35] INFLUENCE OF HLA COMPATIBILITY ON KIDNEY-TRANSPLANTATION
    OPELZ, G
    WUJCIAK, T
    BACK, D
    MYTILINEOS, J
    SCHWARZ, V
    ALBRECHT, G
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1994, 21 (03): : 198 - 202
  • [37] CURRENT STATUS AND DEVELOPMENT OF KIDNEY-TRANSPLANTATION
    KIRSTE, G
    ZENTRALBLATT FUR CHIRURGIE, 1993, 118 (03): : 113 - 117
  • [38] CADAVER KIDNEY-TRANSPLANTATION - ETHICS AND CONSENT
    AUQUIER, P
    REVIRON, D
    ERIN, CA
    SARI, I
    MANUEL, C
    MERCIER, P
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1995, 11 (05) : 495 - 499
  • [39] T cell and cytokine abnormalities in patients with autoimmune thrombocytopenic purpura
    Semple, JW
    TRANSFUSION AND APHERESIS SCIENCE, 2003, 28 (03) : 237 - 242
  • [40] PARTIAL KIDNEY-TRANSPLANTATION - A SUCCESSFUL KIDNEY-TRANSPLANTATION IN A CHILD WITH SEVERE CARDIAC-FAILURE BY SURGICAL MASS REDUCTION OF AN ADULT DONOR KIDNEY
    TAKAHASHI, K
    KAWAGUCHI, H
    YAGISAWA, T
    TANABE, K
    NAKAZAWA, H
    HATTORI, M
    TOMA, H
    ITO, K
    AGISHI, T
    OTA, K
    NAKAZAWA, M
    TRANSPLANT INTERNATIONAL, 1993, 6 (03) : 173 - 175